当前位置: 首页 >> 检索结果
6921. Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.
作者: .;Karina W Davidson.;Michael J Barry.;Carol M Mangione.;Michael Cabana.;Aaron B Caughey.;Esa M Davis.;Katrina E Donahue.;Chyke A Doubeni.;John W Epling.;Martha Kubik.;Li Li.;Gbenga Ogedegbe.;Lori Pbert.;Michael Silverstein.;James Stevermer.;Chien-Wen Tseng.;John B Wong.
来源: JAMA. 2022年327卷4期360-367页
Atrial fibrillation (AF) is the most common cardiac arrhythmia. The prevalence of AF increases with age, from less than 0.2% in adults younger than 55 years to about 10% in those 85 years or older, with a higher prevalence in men than in women. It is uncertain whether the prevalence of AF differs by race and ethnicity. Atrial fibrillation is a major risk factor for ischemic stroke and is associated with a substantial increase in the risk of stroke. Approximately 20% of patients who have a stroke associated with AF are first diagnosed with AF at the time of the stroke or shortly thereafter.
6924. Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19.
作者: Hidde Heesakkers.;Johannes G van der Hoeven.;Stijn Corsten.;Inge Janssen.;Esther Ewalds.;Koen S Simons.;Brigitte Westerhof.;Thijs C D Rettig.;Crétien Jacobs.;Susanne van Santen.;Arjen J C Slooter.;Margaretha C E van der Woude.;Mark van den Boogaard.;Marieke Zegers.
来源: JAMA. 2022年327卷6期559-565页
One-year outcomes in patients who have had COVID-19 and who received treatment in the intensive care unit (ICU) are unknown.
6926. Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
作者: Gavin D Perkins.;Chen Ji.;Bronwen A Connolly.;Keith Couper.;Ranjit Lall.;J Kenneth Baillie.;Judy M Bradley.;Paul Dark.;Chirag Dave.;Anthony De Soyza.;Anna V Dennis.;Anne Devrell.;Sara Fairbairn.;Hakim Ghani.;Ellen A Gorman.;Christopher A Green.;Nicholas Hart.;Siew Wan Hee.;Zoe Kimbley.;Shyam Madathil.;Nicola McGowan.;Benjamin Messer.;Jay Naisbitt.;Chloe Norman.;Dhruv Parekh.;Emma M Parkin.;Jaimin Patel.;Scott E Regan.;Clare Ross.;Anthony J Rostron.;Mohammad Saim.;Anita K Simonds.;Emma Skilton.;Nigel Stallard.;Michael Steiner.;Rama Vancheeswaran.;Joyce Yeung.;Daniel F McAuley.; .
来源: JAMA. 2022年327卷6期546-558页
Continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) have been recommended for acute hypoxemic respiratory failure in patients with COVID-19. Uncertainty exists regarding the effectiveness and safety of these noninvasive respiratory strategies.
6932. The US Supreme Court's Rulings on Large Business and Health Care Worker Vaccine Mandates: Ramifications for the COVID-19 Response and the Future of Federal Public Health Protection.6933. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
作者: Emma K Accorsi.;Amadea Britton.;Katherine E Fleming-Dutra.;Zachary R Smith.;Nong Shang.;Gordana Derado.;Joseph Miller.;Stephanie J Schrag.;Jennifer R Verani.
来源: JAMA. 2022年327卷7期639-651页
Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.
6935. Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period.
作者: Lindsey Wang.;Pamela B Davis.;David C Kaelber.;Nora D Volkow.;Rong Xu.
来源: JAMA. 2022年327卷7期678-680页
This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.
|